Copyright Reports & Markets. All rights reserved.

Global Anti-thrombin III Testing Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Anti-thrombin III Testing Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Diagnosis of antithrombin deficiency
      • 1.4.3 Activity assays
      • 1.4.4 Immunological assays
    • 1.5 Market by Application
      • 1.5.1 Global Anti-thrombin III Testing Market Share by Application (2019-2025)
      • 1.5.2 Hospital
      • 1.5.3 Research institute
      • 1.5.4 Clinic
      • 1.5.5 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Anti-thrombin III Testing Market Size
    • 2.2 Anti-thrombin III Testing Growth Trends by Regions
      • 2.2.1 Anti-thrombin III Testing Market Size by Regions (2019-2025)
      • 2.2.2 Anti-thrombin III Testing Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Anti-thrombin III Testing Market Size by by Players
      • 3.1.1 Global Anti-thrombin III Testing Revenue by by Players (2014-2019)
      • 3.1.2 Global Anti-thrombin III Testing Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Anti-thrombin III Testing Market Concentration Ratio (CR5 and HHI)
    • 3.2 Anti-thrombin III Testing Key Players Head office and Area Served
    • 3.3 Key Players Anti-thrombin III Testing Product/Solution/Service
    • 3.4 Date of Enter into Anti-thrombin III Testing Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Anti-thrombin III Testing Market Size by Type (2014-2019)
    • 4.2 Global Anti-thrombin III Testing Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Anti-thrombin III Testing Market Size (2014-2019)
    • 5.2 Anti-thrombin III Testing Key Players in North America
    • 5.3 North America Anti-thrombin III Testing Market Size by Type
    • 5.4 North America Anti-thrombin III Testing Market Size by Application

    6 Europe

    • 6.1 Europe Anti-thrombin III Testing Market Size (2014-2019)
    • 6.2 Anti-thrombin III Testing Key Players in Europe
    • 6.3 Europe Anti-thrombin III Testing Market Size by Type
    • 6.4 Europe Anti-thrombin III Testing Market Size by Application

    7 China

    • 7.1 China Anti-thrombin III Testing Market Size (2014-2019)
    • 7.2 Anti-thrombin III Testing Key Players in China
    • 7.3 China Anti-thrombin III Testing Market Size by Type
    • 7.4 China Anti-thrombin III Testing Market Size by Application

    8 Japan

    • 8.1 Japan Anti-thrombin III Testing Market Size (2014-2019)
    • 8.2 Anti-thrombin III Testing Key Players in Japan
    • 8.3 Japan Anti-thrombin III Testing Market Size by Type
    • 8.4 Japan Anti-thrombin III Testing Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Anti-thrombin III Testing Market Size (2014-2019)
    • 9.2 Anti-thrombin III Testing Key Players in Southeast Asia
    • 9.3 Southeast Asia Anti-thrombin III Testing Market Size by Type
    • 9.4 Southeast Asia Anti-thrombin III Testing Market Size by Application

    10 India

    • 10.1 India Anti-thrombin III Testing Market Size (2014-2019)
    • 10.2 Anti-thrombin III Testing Key Players in India
    • 10.3 India Anti-thrombin III Testing Market Size by Type
    • 10.4 India Anti-thrombin III Testing Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Anti-thrombin III Testing Market Size (2014-2019)
    • 11.2 Anti-thrombin III Testing Key Players in Central & South America
    • 11.3 Central & South America Anti-thrombin III Testing Market Size by Type
    • 11.4 Central & South America Anti-thrombin III Testing Market Size by Application

    12 International Players Profiles

    • 12.1 Abbott Laboratories
      • 12.1.1 Abbott Laboratories Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Anti-thrombin III Testing Introduction
      • 12.1.4 Abbott Laboratories Revenue in Anti-thrombin III Testing Business (2014-2019))
      • 12.1.5 Abbott Laboratories Recent Development
    • 12.2 Danaher Corp.
      • 12.2.1 Danaher Corp. Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Anti-thrombin III Testing Introduction
      • 12.2.4 Danaher Corp. Revenue in Anti-thrombin III Testing Business (2014-2019)
      • 12.2.5 Danaher Corp. Recent Development
    • 12.3 F. Hoffmann-La Roche Ltd.
      • 12.3.1 F. Hoffmann-La Roche Ltd. Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Anti-thrombin III Testing Introduction
      • 12.3.4 F. Hoffmann-La Roche Ltd. Revenue in Anti-thrombin III Testing Business (2014-2019)
      • 12.3.5 F. Hoffmann-La Roche Ltd. Recent Development
    • 12.4 Siemens Healthcare GmbH
      • 12.4.1 Siemens Healthcare GmbH Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Anti-thrombin III Testing Introduction
      • 12.4.4 Siemens Healthcare GmbH Revenue in Anti-thrombin III Testing Business (2014-2019)
      • 12.4.5 Siemens Healthcare GmbH Recent Development
    • 12.5 Thermo Fisher Scientific Inc.
      • 12.5.1 Thermo Fisher Scientific Inc. Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Anti-thrombin III Testing Introduction
      • 12.5.4 Thermo Fisher Scientific Inc. Revenue in Anti-thrombin III Testing Business (2014-2019)
      • 12.5.5 Thermo Fisher Scientific Inc. Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central & South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Antithrombin (AT, Antithrombin III, ATIII) is a small glycoprotein produced by the liver that inactivates several enzymes of the coagulation system.
      α-Antithrombin is the dominant form of antithrombin found in blood plasma and has an oligosaccharide occupying each of its four glycosylation sites. A single glycosylation site remains consistently un-occupied in the minor form of antithrombin, β-antithrombin.
      Antithrombin activity is increased by anticoagulant heparin, which enhances the binding of antithrombin to factor II and factor X.
      Antithrombin is a serpin (serine protease inhibitor) similar in structure to other plasma protease inhibitors like alpha 1-antichymotrypsin, alpha 2-antiplasmin and Heparin cofactor II.
      In 2018, the global Anti-thrombin III Testing market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Anti-thrombin III Testing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Anti-thrombin III Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      Abbott Laboratories
      Danaher Corp.
      F. Hoffmann-La Roche Ltd.
      Siemens Healthcare GmbH
      Thermo Fisher Scientific Inc.
      ...

      Market segment by Type, the product can be split into
      Diagnosis of antithrombin deficiency
      Activity assays
      Immunological assays

      Market segment by Application, split into
      Hospital
      Research institute
      Clinic
      Other

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Anti-thrombin III Testing status, future forecast, growth opportunity, key market and key players.
      To present the Anti-thrombin III Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Anti-thrombin III Testing are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
      Buy now